Upgrade to SI Premium - Free Trial

SurModics (SRDX) PT Lowered to $63 at Needham & Company

November 1, 2019 7:30 AM
Needham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $63.00 (from $68.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles